Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 266

Similar articles for PubMed (Select 11190417)

1.

Antipsychotic-Induced movement disorders in the elderly: epidemiology and treatment recommendations.

Caligiuri MR, Jeste DV, Lacro JP.

Drugs Aging. 2000 Nov;17(5):363-84. Review.

PMID:
11190417
2.

Antipsychotic-Induced Movement Disorder: Screening via Telemental Health.

Shore J, Vo A, Yellowlees P, Waugh M, Schneck C, Nagamoto H, Thomas M.

Telemed J E Health. 2015 Jun 30. [Epub ahead of print]

PMID:
26125084
3.

Updated views of movement disorders.

Munhoz RP.

Curr Opin Neurol. 2015 Aug;28(4):373-374. No abstract available.

PMID:
26107525
4.

Assessment of Drug Use Disorders.

Katz MH.

JAMA Intern Med. 2015 Jun 15. doi: 10.1001/jamainternmed.2015.2620. [Epub ahead of print] No abstract available.

PMID:
26075629
5.

Drug-induced movement disorders.

Zádori D, Veres G, Szalárdy L, Klivényi P, Vécsei L.

Expert Opin Drug Saf. 2015 Jun;14(6):877-90. doi: 10.1517/14740338.2015.1032244.

PMID:
25981904
6.

Clozapine induced akathisia: a case report and review of the evidence.

Grover S, Sahoo S.

Indian J Pharmacol. 2015 Mar-Apr;47(2):234-5. doi: 10.4103/0253-7613.153441.

7.

Unilateral suppression of probable antipsychotic drug-induced parkinsonism.

Demirci S, Demirci K, Taskiran E, Koyuncuoglu HR.

Acta Neurol Belg. 2015 Mar 19. [Epub ahead of print] No abstract available.

PMID:
25786356
8.

Pharmacogenetics of antipsychotic-induced movement disorders as a resource for better understanding Parkinson's disease modifier genes.

Greenbaum L, Lerer B.

Front Neurol. 2015 Feb 20;6:27. doi: 10.3389/fneur.2015.00027. eCollection 2015. Review.

9.

[Risk factors for tardive movement disorders in schizophrenia].

Tenback DE, Bakker PR, van Harten PN.

Tijdschr Psychiatr. 2015;57(2):120-4. Dutch.

10.

[The genetics of antipsychotic-related movement disorders].

Bakker PR, van Os J, van Harten PN.

Tijdschr Psychiatr. 2015;57(2):114-9. Dutch.

11.
12.

Movement disorders.

Al-Baradie RS.

Neurosciences (Riyadh). 2014 Oct;19(4):341-2. No abstract available.

PMID:
25507865
13.

Tardive dyskinesia and tardive dystonia with second-generation antipsychotics in non-elderly schizophrenic patients unexposed to first-generation antipsychotics: a cross-sectional and retrospective study.

Ryu S, Yoo JH, Kim JH, Choi JS, Baek JH, Ha K, Kwon JS, Hong KS.

J Clin Psychopharmacol. 2015 Feb;35(1):13-21. doi: 10.1097/JCP.0000000000000250.

PMID:
25485636
14.

Movement disorders.

Jankovic J.

Neurol Clin. 2015 Feb;33(1):xv-xvi. doi: 10.1016/j.ncl.2014.10.001. No abstract available.

PMID:
25432734
15.

[Treatment of tardive syndromes].

Horváth K, Aschermann Z, Komoly S, Kovács A, Kovács N.

Psychiatr Hung. 2014;29(2):214-24. Review. Hungarian.

PMID:
25041749
16.

Movement control.

Miller D.

Aust J Physiother. 1966 Dec;12(3):91-4. doi: 10.1016/S0004-9514(14)60964-8.

17.

Incidence of tardive dyskinesia in older adult patients treated with olanzapine or conventional antipsychotics.

Kinon BJ, Kollack-Walker S, Jeste D, Gupta S, Chen L, Case M, Chen J, Stauffer V.

J Geriatr Psychiatry Neurol. 2015 Mar;28(1):67-79. doi: 10.1177/0891988714541867. Epub 2014 Jul 9.

PMID:
25009161
18.

Antipsychotics-induced tardive syndrome: a retrospective epidemiological study.

Lee MJ, Lin PY, Chang YY, Chong MY, Lee Y.

Clin Neuropharmacol. 2014 Jul-Aug;37(4):111-5. doi: 10.1097/WNF.0000000000000040.

PMID:
24992086
19.

Quetiapine in tardive dyskinesia.

Chari S, Jainer A, Ashley-Smith A, Cleaver M.

Int J Psychiatry Clin Pract. 2002;6(3):175-7. doi: 10.1080/136515002760276126.

PMID:
24945206
20.

A case of aripiprazole induced tardive dyskinesia in a neuroleptic-naïve patient with two years of follow up.

Goyal R, Devi SH.

Clin Psychopharmacol Neurosci. 2014 Apr;12(1):69-71. doi: 10.9758/cpn.2014.12.1.69. Epub 2014 Apr 24.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk